Equity Overview
Price & Market Data
Price: $2.89
Daily Change: +$0.0673 / 2.33%
Daily Range: $2.89 - $2.90
Market Cap: $157,647,904
Daily Volume: 2,123
Performance Metrics
1 Week: -2.76%
1 Month: 13.71%
3 Months: 17.50%
6 Months: 89.26%
1 Year: 369.9%
YTD: %
Company Details
Employees: 64
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.